Evidence map›Paper›PMID 20606072›Full record

ArticleAntimicrobial agents and chemotherapy2010

Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.

Muhamed-Kheir Taha, Sara Thulin Hedberg, Marek Szatanik, Eva Hong, Corinne Ruckly, Raquel Abad, Sophie Bertrand, Francoise Carion, Heike Claus, Alejandra Corso and 18 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. CharacterizingIJID regions · 2024
    Article
  2. Genetic characterization ofFrontiers in cellular and infection microbiology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  7. Article
  8. First report of meningococcal ciprofloxacin resistance in Greece due to invasive isolates of the sequence type ST-3129.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  9. Article
  10. Article
  11. Establishment of the European meningococcal strain collection genome library (EMSC-GL) for the 2011 to 2012 epidemiological year.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Automated extraction of typing information for bacterial pathogens from whole genome sequence data: Neisseria meningitidis as an exemplar.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2013
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 12 countries.

Muhamed-Kheir TahaInstitut Pasteur, National Reference Centre for Meningococci, 28 Rue du Dr. Roux, Paris, France. mktaha@pasteur.fr
Sara Thulin Hedberg
Marek Szatanik
Eva Hong
Corinne Ruckly
Raquel Abad
Sophie Bertrand
Francoise Carion
Heike Claus
Alejandra Corso
Rocío Enríquez
Sigrid Heuberger
Waleria Hryniewicz
Keith A Jolley
Paula Kriz
Marta Mollerach
Martin Musilek
Arianna Neri
Per Olcén
Marina Pana
Anna Skoczynska
Cecilia Sorhouet Pereira
Paola Stefanelli
Georgina Tzanakaki
Magnus Unemo
Julio A Vázquez
Ulrich Vogel
Izabela Wasko
Institut Pasteur · FRInstituto de Salud Carlos III · ESNarodowy Instytut Leków · PLÖrebro University Hospital · SEAdministración Nacional de Laboratorios e Institutos de Salud · ARInstitut Scientifique de Santé Publique · BEIstituto Superiore di Sanità · ITUniversity of Würzburg · DEAustrian Agency for Health and Food Safety · ATInstitutul Cantacuzino · RONational School of Public Health · GRUniversity of Buenos Aires · ARUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of clinical isolates of Neisseria meningitidis that are resistant to rifampin is important to avoid prophylaxis failure in contacts of patients, but it is hindered by the absence of a breakpoint for resistance, despite many efforts toward standardization. We examined a large number (n = 392) of clinical meningococcal isolates, spanning 25 years (1984 to 2009), that were collected in 11 European countries, Argentina, and the Central African Republic. The collection comprises all clinical isolates with MICs of > or = 0.25 mg/liter (n = 161) received by the national reference laboratories for meningococci in the participating countries. Representative isolates displaying rifampin MICs of < 0.25 mg/liter were also examined (n = 231). Typing of isolates was performed, and a 660-bp DNA fragment of the rpoB gene was sequenced. Sequences differing by at least one nucleotide were defined as unique rpoB alleles. The geometric mean of the MICs was calculated for isolates displaying the same allele. The clinical isolates displaying rifampin MICs of > 1 mg/liter possessed rpoB alleles with nonsynonymous mutations at four critical amino acid residues, D542, H552, S548, and S557, that were absent in the alleles found in all isolates with MICs of < or = 1 mg/liter. Rifampin-susceptible isolates could be defined as those with MICs of < or = 1 mg/liter. The rpoB allele sequence and isolate data have been incorporated into the PubMLST Neisseria database (http://pubmlst.org/neisseria/). The rifampin-resistant isolates belonged to diverse genetic lineages and were associated with lower levels of bacteremia and inflammatory cytokines in mice. This biological cost may explain the lack of clonal expansion of these isolates.

Indexed as

Amino Acid SequenceAnimalsAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialFemaleMiceMice, Inbred BALB CMice, TransgenicMicrobial Sensitivity TestsMolecular Sequence DataNeisseria meningitidisPhylogenyRifampinAnti-Bacterial AgentsBacterial ProteinsRifampin

Identifiers

PMID20606072
PMCPMC2934967
OpenAlexW2169676110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.